Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

US: Vireo Growth closes WholesomeCo and Arches transactions

Vireo Growth has closed its previously-announced transactions to acquire Utah-based WholesomeCo Cannabis and the Arches proprietary technology and analytics platform.

Total consideration for the transactions was $69.8 million, paid in the form of 134.2 million Subordinate Voting Shares of Vireo at a reference price per share of $0.52. The purchase price of the Wholesome transaction represents a multiple of 4.175x 2024 "Reference EBITDA" of $16 million. The Wholesome transaction is subject to clawback provisions if they don't meet performance milestones as of December 31, 2026. The selling shareholders all agreed to voluntary share lock-up provisions, with tranches of shares unlocking over a 33-month period.

The acquisitions of Wholesome and Arches are expected to further strengthen the Company's profitability profile and provide a unique opportunity to build competitive advantages in other markets with a proprietary technology and analytics platform. Vireo management continues to expect that its other pending merger transactions will close during the second quarter.

For more information:
Vireo
vireohealth.com